However, the expression levels of KDM5D were exclusively associated with the gender of PDAC patients (Fig. 2H), and not with other clinical factors such as tumor stage, grade, and lymph node metastasis. This evidence concerns the gene KDM5D and metastatic malignant neoplasm in the lymph nodes.